aTyr Pharma Inc.
ATYR:NASDAQ
aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr's research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.
Streetwise Company Fact Sheet2025/11/13 22:49:05
(ATYR:NASDAQ)
Analyst coverage
| Laidlaw & Company — Dr. Yale Jen |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
Streetwise Reports Articles
| 11/13/2025 - View Article |
Streetwise - aTyr Pharma Inc. Ownership Overview*
aTyr Pharma Inc. (ATYR:NASDAQ)
*Share Structure as of 11/13/2025
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
